Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Clinical trial NCT06615557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06615557
- Sponsor
- VistaGen Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-16
- Primary completion
- 2026-04-21
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.